OrthoPediatrics Corp. (KIDS) Receives New Coverage from Analysts at William Blair
A number of other research firms have also issued reports on KIDS. Stifel Nicolaus started coverage on OrthoPediatrics Corp. in a report on Monday. They issued a “buy” rating and a $23.00 target price for the company. BTIG Research started coverage on OrthoPediatrics Corp. in a report on Monday. They set a “buy” rating and a $24.00 price target for the company. Finally, Piper Jaffray Companies started coverage on OrthoPediatrics Corp. in a report on Monday. They set an “overweight” rating and a $24.00 price target for the company.
OrthoPediatrics Corp. (NASDAQ:KIDS) traded up $1.76 during trading hours on Monday, reaching $22.56. The company had a trading volume of 25,652 shares, compared to its average volume of 259,746. OrthoPediatrics Corp. has a 52-week low of $17.03 and a 52-week high of $21.00.
In other OrthoPediatrics Corp. news, Director Harold Ruf bought 11,500 shares of the company’s stock in a transaction on Monday, October 16th. The shares were bought at an average price of $13.00 per share, for a total transaction of $149,500.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
OrthoPediatrics Corp. Company Profile
OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.
Receive News & Ratings for OrthoPediatrics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.